WallStreetZenWallStreetZen

NYSE: BMY
Bristol Myers Squibb Co Stock Forecast, Predictions & Price Target

Analyst price target for BMY

Based on 15 analysts offering 12 month price targets for Bristol Myers Squibb Co.
Min Forecast
$50.00-3.21%
Avg Forecast
$60.40+16.92%
Max Forecast
$84.00+62.6%

Should I buy or sell BMY stock?

Based on 15 analysts offering ratings for Bristol Myers Squibb Co.
Hold
Strong Buy
3 analysts 20%
Buy
0 analysts 0%
Hold
11 analysts 73.33%
Sell
0 analysts 0%
Strong Sell
1 analysts 6.67%

Be the first to know when Wall Street analysts revise their BMY stock forecasts and price targets.

BMY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-06
lockedlocked$00.00+00.00%2024-02-06
lockedlocked$00.00+00.00%2024-01-03
lockedlocked$00.00+00.00%2023-11-15
lockedlocked$00.00+00.00%2023-11-09
Daiwa Capital
Bottom 47%
47
HoldDowngrades$54.00+4.53%2023-11-02
Goldman Sachs
Top 17%
84
Strong BuyMaintains$69.00+33.57%2023-10-30
Morgan Stanley
Top 8%
93
Strong SellMaintains$50.00-3.21%2023-10-27
Barclays
Top 18%
83
HoldMaintains$51.00-1.28%2023-10-27
BMO Capital
Bottom 16%
16
HoldDowngrades$60.00+16.14%2023-10-27

1 of 2

Forecast return on equity

Is BMY forecast to generate an efficient return?
Company
N/A
Industry
14.56%
Market
37.62%

Forecast return on assets

Is BMY forecast to generate an efficient return on assets?
Company
N/A
Industry
5.77%

BMY revenue forecast

What is BMY's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$46.1B+2.44%
Avg 2 year Forecast
$46.4B+3.09%
Avg 3 year Forecast
$44.5B-1.1%
BMY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BMY earnings growth forecast

How is BMY forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
31.73%
Industry
43.55%
Market
21.53%
BMY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
BMY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
BMY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

BMY revenue growth forecast

How is BMY forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
-0.1%
Industry
8.86%
Market
10%
BMY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BMY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BMY vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
BMY$51.66$60.40+16.92%Hold
GILD$73.55$83.50+13.53%Hold
GSK$42.22$46.00+8.95%Buy
SNY$48.77$55.00+12.77%Hold
AMGN$289.18$309.67+7.08%Buy

Bristol Myers Squibb Co Stock Forecast FAQ

Is Bristol Myers Squibb Co Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 15 Wall Street analysts covering (NYSE: BMY) stock is to Hold BMY stock.

Out of 15 analysts, 3 (20%) are recommending BMY as a Strong Buy, 0 (0%) are recommending BMY as a Buy, 11 (73.33%) are recommending BMY as a Hold, 0 (0%) are recommending BMY as a Sell, and 1 (6.67%) are recommending BMY as a Strong Sell.

If you're new to stock investing, here's how to buy Bristol Myers Squibb Co stock.

What is BMY's revenue growth forecast for 2024-2026?

(NYSE: BMY) Bristol Myers Squibb Co's forecast annual revenue growth rate of -0.1% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.86%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10%.

Bristol Myers Squibb Co's revenue in 2024 is $45,006,000,000.On average, 6 Wall Street analysts forecast BMY's revenue for 2024 to be $93,235,219,074,665, with the lowest BMY revenue forecast at $91,676,259,619,290, and the highest BMY revenue forecast at $94,977,571,250,484. On average, 6 Wall Street analysts forecast BMY's revenue for 2025 to be $93,825,446,776,500, with the lowest BMY revenue forecast at $90,998,117,058,911, and the highest BMY revenue forecast at $97,724,316,560,645.

In 2026, BMY is forecast to generate $90,006,000,660,766 in revenue, with the lowest revenue forecast at $84,777,708,573,136 and the highest revenue forecast at $98,303,068,314,873.

What is BMY's forecast return on assets (ROA) for 2024-2027?

(NYSE: BMY) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - General industry average of 5.77%.

What is BMY's Price Target?

According to 15 Wall Street analysts that have issued a 1 year BMY price target, the average BMY price target is $60.40, with the highest BMY stock price forecast at $84.00 and the lowest BMY stock price forecast at $50.00.

On average, Wall Street analysts predict that Bristol Myers Squibb Co's share price could reach $60.40 by Feb 6, 2025. The average Bristol Myers Squibb Co stock price prediction forecasts a potential upside of 16.92% from the current BMY share price of $51.66.

What is BMY's forecast return on equity (ROE) for 2024-2027?

(NYSE: BMY) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.